These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
322 related articles for article (PubMed ID: 25039470)
1. Formulation and pharmacokinetics of gelucire solid dispersions of flurbiprofen. Daravath B; Tadikonda RR; Vemula SK Drug Dev Ind Pharm; 2015; 41(8):1254-62. PubMed ID: 25039470 [TBL] [Abstract][Full Text] [Related]
2. Physicochemical characterization and in vivo evaluation of flurbiprofen-loaded solid dispersion without crystalline change. Oh DH; Park YJ; Kang JH; Yong CS; Choi HG Drug Deliv; 2011 Jan; 18(1):46-53. PubMed ID: 20726805 [TBL] [Abstract][Full Text] [Related]
3. Preparation and in vitro characterization of a semi-solid dispersion of flurbiprofen with Gelucire 44/14 and Labrasol. Soliman MS; Khan MA Pharmazie; 2005 Apr; 60(4):288-93. PubMed ID: 15881610 [TBL] [Abstract][Full Text] [Related]
4. Cefuroxime axetil solid dispersion with polyglycolized glycerides for improved stability and bioavailability. Dhumal RS; Biradar SV; Aher S; Paradkar AR J Pharm Pharmacol; 2009 Jun; 61(6):743-51. PubMed ID: 19505364 [TBL] [Abstract][Full Text] [Related]
6. Enhanced solubility and bioavailability of flurbiprofen by cycloamylose. Baek HH; Kwon SY; Rho SJ; Lee WS; Yang HJ; Hah JM; Choi HG; Kim YR; Yong CS Arch Pharm Res; 2011 Mar; 34(3):391-7. PubMed ID: 21547670 [TBL] [Abstract][Full Text] [Related]
7. A novel osmotic pump-based controlled delivery system consisting of pH-modulated solid dispersion for poorly soluble drug flurbiprofen: in vitro and in vivo evaluation. Li S; Wang X; Wang Y; Zhao Q; Zhang L; Yang X; Liu D; Pan W Drug Dev Ind Pharm; 2015; 41(12):2089-99. PubMed ID: 26304493 [TBL] [Abstract][Full Text] [Related]
8. Formulation and pharmacokinetics of ketorolac tromethamine fast dissolving tablets. Mettu SR; Veerareddy PR Drug Res (Stuttg); 2013 Nov; 63(11):586-90. PubMed ID: 23780501 [TBL] [Abstract][Full Text] [Related]
9. Enhancement of the in-vitro dissolution and in-vivo oral bioavailability of silymarin from liquid-filled hard gelatin capsules of semisolid dispersion using Gelucire 44/14 as a carrier. Hussein A; El-Menshawe S; Afouna M Pharmazie; 2012 Mar; 67(3):209-14. PubMed ID: 22530301 [TBL] [Abstract][Full Text] [Related]
10. Enhanced dissolution and bioavailability of grapefruit flavonoid Naringenin by solid dispersion utilizing fourth generation carrier. Khan AW; Kotta S; Ansari SH; Sharma RK; Ali J Drug Dev Ind Pharm; 2015 May; 41(5):772-9. PubMed ID: 24669978 [TBL] [Abstract][Full Text] [Related]
11. Preparation and characterization of spironolactone-loaded gelucire microparticles using spray-drying technique. Yassin AE; Alanazi FK; El-Badry M; Alsarra IA; Barakat NS; Alanazi FK Drug Dev Ind Pharm; 2009 Mar; 35(3):297-304. PubMed ID: 18821154 [TBL] [Abstract][Full Text] [Related]
12. Effect of semicrystalline copolymers in solid dispersions of pioglitazone hydrochloride: in vitro-in vivo correlation. Swain RP; Subudhi BB Drug Dev Ind Pharm; 2019 May; 45(5):775-786. PubMed ID: 30675819 [TBL] [Abstract][Full Text] [Related]
13. Improved solubility and dissolution rate of piroxicam using gelucire 44/14 and labrasol. Karataş A; Yüksel N; Baykara T Farmaco; 2005 Sep; 60(9):777-82. PubMed ID: 16084514 [TBL] [Abstract][Full Text] [Related]
14. Characteristics of rofecoxib-polyethylene glycol 4000 solid dispersions and tablets based on solid dispersions. Liu C; Desai KG Pharm Dev Technol; 2005; 10(4):467-77. PubMed ID: 16370176 [TBL] [Abstract][Full Text] [Related]
15. Development of prednisone:polyethylene glycol 6000 fast-release tablets from solid dispersions: solid-state characterization, dissolution behavior, and formulation parameters. Leonardi D; Barrera MG; Lamas MC; Salomón CJ AAPS PharmSciTech; 2007 Dec; 8(4):E108. PubMed ID: 18181529 [TBL] [Abstract][Full Text] [Related]
16. Study of in-vitro release characteristics of carbamazepine extended release semisolid matrix filled capsules based on Gelucires. Galal S; El Massik MA; Abdallah OY; Daabis NA Drug Dev Ind Pharm; 2004 Sep; 30(8):817-29. PubMed ID: 15521328 [TBL] [Abstract][Full Text] [Related]
17. Influence of the oral dissolution time on the absorption rate of locally administered solid formulations for oromucosal use: the flurbiprofen lozenges paradigm. Imberti R; De Gregori S; Lisi L; Navarra P Pharmacology; 2014; 94(3-4):143-7. PubMed ID: 25277061 [TBL] [Abstract][Full Text] [Related]
18. Novel lipid-based formulations enhancing the in vitro dissolution and permeability characteristics of a poorly water-soluble model drug, piroxicam. Prabhu S; Ortega M; Ma C Int J Pharm; 2005 Sep; 301(1-2):209-16. PubMed ID: 16046087 [TBL] [Abstract][Full Text] [Related]
19. Development and characterization of solid dispersion-microsphere controlled release system for poorly water-soluble drug. Malipeddi VR; Dua K; Awasthi R Drug Deliv Transl Res; 2016 Oct; 6(5):540-50. PubMed ID: 27343081 [TBL] [Abstract][Full Text] [Related]
20. Novel dual-reverse thermosensitive solid lipid nanoparticle-loaded hydrogel for rectal administration of flurbiprofen with improved bioavailability and reduced initial burst effect. Din FU; Mustapha O; Kim DW; Rashid R; Park JH; Choi JY; Ku SK; Yong CS; Kim JO; Choi HG Eur J Pharm Biopharm; 2015 Aug; 94():64-72. PubMed ID: 25979136 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]